Details for New Drug Application (NDA): 022101
✉ Email this page to a colleague
The generic ingredient in NEXIUM is esomeprazole sodium. There are seventy-four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the esomeprazole sodium profile page.
Summary for 022101
Tradename: | NEXIUM |
Applicant: | Astrazeneca |
Ingredient: | esomeprazole magnesium |
Patents: | 0 |
Pharmacology for NDA: 022101
Mechanism of Action | Cytochrome P450 2C19 Inhibitors Proton Pump Inhibitors |
Suppliers and Packaging for NDA: 022101
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NEXIUM | esomeprazole magnesium | FOR SUSPENSION, DELAYED RELEASE;ORAL | 022101 | NDA | AstraZeneca Pharmaceuticals LP | 0186-4010 | 0186-4010-01 | 30 GRANULE, DELAYED RELEASE in 1 CARTON (0186-4010-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION, DELAYED RELEASE;ORAL | Strength | EQ 10MG BASE/PACKET | ||||
Approval Date: | Feb 27, 2008 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 022101
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astrazeneca | NEXIUM | esomeprazole magnesium | FOR SUSPENSION, DELAYED RELEASE;ORAL | 022101-001 | Feb 27, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Astrazeneca | NEXIUM | esomeprazole magnesium | FOR SUSPENSION, DELAYED RELEASE;ORAL | 022101-001 | Feb 27, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Astrazeneca | NEXIUM | esomeprazole magnesium | FOR SUSPENSION, DELAYED RELEASE;ORAL | 022101-001 | Feb 27, 2008 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription